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Anti-neutrophil cytoplasmic autoantibodies (ANCA)
react with constituents ofneutrophilprimarygran-
ules and monocyte lysosomes. Indirect immuno-
fluorescence microscopy using alcohol-fixed neu-
trophils demonstrates twoANCA types: one causing
cytoplasmic staining (C-ANCA), and a second
causing artifactualperinuclear staining (P-ANCA)
thatfrequently has specificityfor myeloperoxidase.
Using indirect immunofluorescence microscopy
(IIFM) and enzyme immunoassays (EIA), sera
from over 300patients with renal disease, with and
without systemic vasculitis, were analyzed. Of 76
patients with pauci-immune glomerulonephritis
with crescents or necrosis, 87% hadANCA by IIFM
(38% of C-ANCA type, 49% ofP-ANCA type), and
78% hadANCA by EIA. Of55patients with nonlu-
pus immune complex-mediated glomerulonephri-
tis, only 11% hadANCA byIIFMand5% hadANCA
by EIA. Of24patients with anti-GBMantibody-me-
diated glomerulonephritis, none had ANCA. Renal
and extrarenal lesions were studied in 81 patients
with ANCA-associated glomerulonephritis. These
patients formed a pathologic continuum ranging
from renal-limited to widespread systemic vascular
injury, including patients with primary crescentic
glomerulonephritis, Wegener's granulomatosis,
and polyarteritis nodosa. In ANCA-positive pa-
tients thefrequency ofC-ANCA and P-ANCA corre-
lated with disease distribution. P-ANCA was most
frequent with renal-limited disease and C-ANCA
was mostfrequent when there was lung and sinus
involvement. It isproposed that ANCA are not only
useful diagnostic markers, but may also be directly
involved in a novel pathogenetic mechanism that
is afrequent cause ofcrescenticglomerulonephritis
and systemic necrotizing vasculitis. (Am J Pathol
1989, 135:921-930)
The clinical and pathologic diagnosis of systemic necro-
tizing vasculitis is difficult. A major confounding problem
is that different pathogenetic mechanisms can produce
structurally similar vascular lesions. Therefore, diagnostic
classification systems based solely on morphology are in-
adequate for optimum categorization. Pathogenetic clas-
sification systems have suffered from the problem that a
large proportion of vasculitides do not show convincing
evidence for mediation by the two most widely recog-
nized mechanisms, ie, immune complex-mediated injury
and anti-basement membrane autoantibody-mediated in-
jury. We propose that there is a third major mechanism of
vascular injury that involves direct activation of neutrophils
and mononuclear phagocytes by anti-neutrophil cytoplas-
mic autoantibodies (ANCA). If this mechanism exists, acti-
vated leukocytes would attack vessel walls, producing in-
jury similar to that caused by immune complex localization
or anti-basement membrane antibody binding.
ANCA were first reported by Davies et a1l in eight pa-
tients with hematuria and arthralgias or myalgias. Four of
these patients had dyspnea or hemoptysis and two had
extensive pulmonary disease identified radiographically.
On renal biopsy, all eight patients had segmental necrotiz-
ing glomerulonephritis with crescent formation and no im-
mune deposits by immunofluorescence microscopy. In
1984, Hall et a12 reported on four ANCA-positive patients.
All four patients had arthralgias and pulmonary disease.
Three of the four had focal necrotizing glomerulonephritis,
two had cutaneous vasculitis, and two had gastrointesti-
nal symptoms.2 In 1985, van der Woude et a13 demon-
strated a high sensitivity of ANCA for active Wegener's
granulomatosis and noted that the presence of ANCA
correlated with disease activity. The correlation of ANCA
titer with disease activity in Wegener's granulomatosis pa-
tients was confirmed by Gross et al.4 Subsequent studies
identified ANCA in patients with Wegener's granulomato-
sis, polyarteritis nodosa, Churg-Strauss syndrome, and
pauci-immune necrotizing glomerulonephritis.512
ANCA react with antigens in the cytoplasm of neutro-
phils and monocytes. These antigens are in the primary
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Table 1. The Occurrence ofANCA*
IIFM EIA
No. Positive C-ANCA P-ANCA Mean Positivet
Pauci-immune necrotizing GN 76 66(87%) 29(38%) 37 (49%) 75.5 59(78%)
Anti-GBM-mediated GN 24 0 (0%) 0 (0%) 0 (0%) 19.9 0 (0%)
Immune complex-mediated
GN (nonlupus) 55 4(7%) 0 (0%) 4(7%) 23.3 3(5%)
* In patients with biopsy-proven pauci-immune necrotizing GN, anti-GBM antibody-mediated GN and nonlupus immune complex mediated GN.
t A positive EIA level was considered to be a value greater than the mean plus two standard deviations of 83 blood bank control specimens, ie, greater
than 42.2.
granules of neutrophils'0 and in the lysosomes of mono-
cytes. All ANCA, however, do not have specificity for the
same granule constituents. Because of different specific-
ities, by indirect immunohistology different ANCA types
produce different immunostaining patterns on alcohol-
fixed neutrophils. Of the two major ANCA types, one (C-
ANCA), which appears to have specificity for an approxi-
mately 30 kd component of primary granules,'3 produces
cytoplasmic staining with central accentuation (Figure
1A). The second type (P-ANCA), usually having myeloper-
oxidase specificity in patients with renal disease,10 pro-
duces artifactual perinuclear staining of alcohol-fixed neu-
trophils (Figure 11B) but cytoplasmic staining of formalin-
fixed neutrophils (Figure 1 C). The type of ANCA present
correlates to a degree with the distribution and nature of
vascular injury; for example, as will be documented later,
patients with Wegener's granulomatosis have a higher
frequency of C-ANCA whereas patients with pauci-im-
mune necrotizing glomerulonephritis and no evidence of
extrarenal disease have a higher frequency of P-ANCA. 1 1
In this article we present data indicating that ANCA are
present in the blood of patients with a number of necrotiz-
ing vasculitic syndromes that lie within a continuum of
ANCA-associated vascular injury. We also give patho-
logic descriptions of the renal and extrarenal lesions ob-
served in patients with ANCA, which indicate that some
of these patients meet the clinicopathologic criteria for
polyarteritis nodosa, Wegener's granulomatosis, or pauci-
immune ("idiopathic") necrotizing glomerulonephritis,
whereas others have clinical and pathologic features that
overlap among these syndromes.
We propose that ANCA are not only a marker that will
facilitate classification of vasculitides and glomerulone-
phritides, but also are pathogenetic factors in a previously
unrecognized mechanism of immune-mediated tissue in-
jury.
Materials and Methods
Tissue Specimens and Serum Samples
All patients in this study had renal disease with or without
evidence for systemic vasculitis. All patients underwent
renal biopsy. All renal biopsy specimens were evaluated
by the Nephropathology Laboratory of the University of
North Carolina at Chapel Hill. Renal biopsies were exam-
ined by standard light, immunofluorescence, and electron
microscopy techniques.14 Three different series of pa-
tients selected by different criteria were analyzed to deter-
mine the following: 1) The association of ANCA with
different immunohistopathologic categories of renal dis-
ease (more than 300 patients with renal biopsy immuno-
fluorescence microscopy data and ANCA data were ana-
lyzed). 2) The frequency of ANCA-associated glomerulo-
nephritis among all patients with renal disease (the renal
biopsy findings in 1500 consecutive nontransplant renal
biopsies were evaluated). 3) The range of pathologic renal
and extrarenal changes in patients with ANCA-associated
glomerulonephritis (81 patients with ANCA and glomeru-
lonephritis were evaluated by renal biopsy).
The clinical data were thoroughly analyzed in 65 of the
81 patients with ANCA-associated glomerulonephritis.
Forty-five of these patients had evidence of systemic vas-
culitis, including patients with the diagnostic criteria for
Wegener's granulomatosis and polyarteritis nodosa. For
17 patients with ANCA-associated glomerulonephritis
who had evidence of systemic disease, extrarenal tissues
were available for examination by light, immunofluores-
cence, or electron microscopy, or all three, including 15
lung specimens, seven skin biopsies, eight nasal mucosa
biopsies, and one autopsy.
For ANCA analysis, serum samples were obtained
from over 200 patients who underwent renal biopsy evalu-
ation at the University of North Carolina. In addition, 58
serum samples from IgA nephropathy patients were sup-
plied by Dr. H. K. Yapp, National University of Singapore
and Dr. S. C. Jordan, Cedars-Sinai Medical Center; 15
serum samples from patients with pathologically and se-
rologically documented anti-GBM glomerulonephritis
were supplied by Dr. A. J. Fish, University of Minnesota.
Specimens from 83 blood bank donors served as normal
controls.
ANCA Assays
ANCA were assayed in sera by both indirect immunofluo-
rescence microscopy (IIFM) and enzyme immunoassay
(EIA) using previously published methods.'0 Immunofluo-
rescence microscopy preparations were determined to
Anti-Neutrophil Autoantibodies 923
AJPNovember 1989, Vol. 135, No. 5
be positive or negative; when positive, they were noted
to have either a cytoplasmic (C-ANCA) or perinuclear (P-
ANCA) (Figure 1 A, B) pattern. These patterns distinguish
between the two major types of ANCA. The artifactual
perinuclear distribution of staining seen with P-ANCA is
caused by the solubilization and binding of a nucleophilic
cytoplasmic constituent, usually myeloperoxidase (MPO),
Figure 1. Indir ct inmnun1olluort'scence rnicroscopy staiuitig
patternl of ( -AWINA_I anid P-ANGA primar antibody uIsing nior-
mzal hIumiant neitutropbils as substrate andfltuorescein-conjii-
gatcd anESti- hul?man lg(G assecondCaV-rylanstibod!. A: Alcohol-fixed
neutrophils ittert us'.,dassibst?ratct auZddernionstrateda tjpica
C-ANCA staining Pattern with central acceItuiatiotn. B: Alct-
hol-fixd nueutrophils wvere uised a/lowing the artifjctual redis-
tribz Ntion 0f nu clopbilic cytoplasmnic antigens (eg, MP110) that
resuIlts in)P-ANsCApcrinzCcear staininig. C: Formalitn -fixednie 7i-
trophi/ls wereiised topPrevtient anitten redistribuuItion, res ultinig
in cy tsoplasniic staininig nit?) the. samie P-ANCA at the same dil/-
tiont zised in panite/A (originalmanagniiificattio x 1000).
to neutrophil nuclei during preparation of the alcohol-fixed
substrate.15 ANCA determinations were made without
knowledge of the renal biopsy findings or clinical presen-
tations of the patients.
A screening EIA'° using an antigen substrate enriched
for neutrophil cytoplasmic granule constituents that de-
tects all ANCA was performed on all sera. A specific EIA
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using myeloperoxidase (MPO)10 was performed on 117
sera from 45 patients with P-ANCA-associated glomerulo-
nephritis, 29 patients with C-ANCA glomerulonephritis, 16
patients with lupus nephritis, and 27 patients with no
ANCA by IIFM. EIA values were expressed as the percent-
age of a standard positive control sample reaction. A
standard negative control was evaluated in each assay,
and the mean value from 33 assays was 19.1, with a stan-
dard deviation of 8.4. Triplicate EIA analysis of the prelimi-
nary ANCA International Serum Standard (obtained from
Dr. Niels Rasmussen, Statens Seruminstitut, Copenha-
gen, Denmark) yielded a mean of 99.9 with a standard
deviation of 17.2. Eighty-three normal blood bank sam-
ples were evaluated having a mean value of 23.2, with a
standard deviation of 9.5. Patient results were considered
positive when they were greater than two standard devia-
tions above this mean value for normal blood bank donor
samples, ie, greater than 42.2.
Serum samples from ANCA-associated glomerulone-
phritis patients were also evaluated by IIFM for antinuclear
antibodies and anti-DNA antibodies using HEp-2 cells for
the former and Crithedia luciliae for the latter (Behring Di-
agnostics, La Jolla, CA).
Categorization of Patients
For the purposes of this study, ANCA-associated glomer-
ulonephritis was defined as any form of glomerulonephri-
tis, other than lupus nephritis, in a patient with a positive
ANCA by IIFM. Glomerulonephritis was categorized as
nonlupus immune complex-mediated (defined as the
presence of 2+ or greater granular mesangial or capillary
wall immunostaining for IgG, IgA, or IgM, and no clinical or
pathologic evidence for systemic lupus erythematosus),
anti-GBM antibody-mediated (defined by 3+ or greater
linear GBM immunostaining for IgG and confirmation of
anti-GBM in the serum), or pauci-immune (defined as less
than 2+ glomerular immunostaining for immunoglobu-
lins).
By medical chart review and review of pathologic
specimens, 65 patients with ANCA-associated glomerulo-
nephritis were categorized according to the apparent ex-
tent of extrarenal inflammatory disease into the following
categories: A) Renal-limited disease; B) renal and extrare-
nal disease but no lung disease; C) renal and extrarenal
disease with lung but no sinus disease; D) renal and extra-
renal disease with both lung and sinus disease.
Statistical Analysis
One-way analysis of variance was used to detect any
differences among groups of patients with respect. to the
demographic, pathologic, and serologic parameters un-
der study. When significant differences were detected
among groups, Fisher's test for least significant differ-
ences was carried out to compare the groups.
Results
Association ofANCA with Pauci-Immune
Necrotizing Glomerulonephritis and
Systemic Necrotizing Vasculitis
As shown in Table 1 and Figure 2, ANCA were strongly
associated with pauci-immune necrotizing and crescent-
forming glomerulonephritis, but not with nonlupus im-
mune complex-mediated or anti-GBM antibody-mediated
glomerulonephritis. Both C-ANCA and P-ANCA IIFM stain-
ing patterns were identified in patients with pauci-immune
glomerulonephritis. In 30 patients, 122 replicate positive
sera were analyzed over time with no change in ANCA
pattern in a given patient ever observed. At some time
during follow-up, serum samples from 22 patients be-
came negative for ANCA.
As shown in Figure 3, the P-ANCA pattern correlated
with anti-MPO specificity, whereas the C-ANCA pattern
did not. P-ANCA sera gave a mean MPO EIA value of 72.1
± 22.2, which was significantly greater (P < 0.01) than the
mean for C-ANCA sera (36.5 ± 12.0) and ANCA-negative
sera (25.4 ± 1 1.1). The latter two means were not signifi-
cantly different. Eighty-nine percent (40 of 45) of P-ANCA
sera had an MPO EIA value greater than the negative con-
trol mean plus two standard deviations, compared with
only 14% (four of 29) of C-ANCA sera.
For inclusion in the pauci-immune glomerulonephritis
category, patients had to have either glomerular cres-
cents or necrosis. Using these criteria, all but two of the
76 patients in the pauci-immune category had crescent
formation and all but three had glomerular necrosis. The
percentage of glomeruli with crescents ranged from 0%
to 100%, with a mean of 43.8%. Of the 76 patients, 32
had 50% or more of glomeruli with crescents.
Of the 55 patients with nonlupus immune complex-me-
diated glomerulonephritis, 16 had crescent formation in-
volving from 5% to 95% of glomeruli, including six patients
with 50% or more glomerular crescents. Included in the
immune complex-mediated glomerulonephritis category
were 17 patients with IgA nephropathy and 22 patients
with membranous glomerulopathy. The three patients in
the immune complex category who had positive ANCA
values by EIA were also positive by IIFM and only margin-
ally met our working criteria for immune complex rather
than pauci-immune glomerulonephritis. One of these pa-
tients had 2+ IgA glomerular immunostaining with small
numbers of mesangial dense deposits and had acute si-
nusitis and pulmonary capillaritis with hemoptysis. The
second had only 2+ IgG irregular glomerular immuno-
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Figure 2. Screening EIA ANCA valuesfrom
76patients withpauci-immune glomerulo-
nepbritis with associated crescents or ne-
crosis, 55 patients with nonlupus immune
complex - mediated glomerulonephritis,
and 24 patients with anti-GBM antibody-
mediated glomerulonephritis. ANCA val-
ues are expressed as the percentage reac-
tivity relative to a standard positive con-
trol. The dashed line represents the mean
plus 2 SD value obtained for 83 normal


















staining with no electron dense deposits ultrastructurally.
The third had necrotizing glomerulonephritis with 95%
crescents, 2+ glomerular IgG, and scattered glomerular
dense deposits.
An additional 58 sera from IgA nephropathy patients
(provided by Dr. H. K. Yapp and Dr. S. C. Jordan) were
analyzed by EIA for ANCA. These sera had a mean EIA
value of 14.3 ± 10.8, with only one sample giving a posi-
tive value (ie, greater than 42.2). Nine positive sera run
concurrently with the IgA nephropathy sera had a mean
of 95.6 ± 23.3, and ten negative sera had a mean of 13.9
10.2.
The anti-GBM glomerulonephritis group was com-
prised of nine patients diagnosed at the University of
North Carolina and 15 patients diagnosed at the Univer-
sity of Minnesota. The diagnosis was confirmed in all pa-
tients both by renal biopsy and by serologic identification
of anti-GBM antibodies.
Serum samples from 18 patients with biopsy-proven




















C-ANCA pattern, but ten (56%) had nuclear staining that
could not be readily distinguished from P-ANCA staining
on alcohol-fixed cells. By the screening EIA, the lupus sera
had a mean value of 76.0, and 14 (78%) were positive (ie,
greater than 42.2). However, 16 sera from patients with
biopsy-proven lupus nephritis gave a mean MPO EIA
value of 38.4, which was not significantly different from
the negative control mean of 25.4 and was significantly
lower than the P-ANCA-associated pauci-immune glomer-
ulonephritis mean of 72.1 (P < 0.01). Only two of 16 lupus
patients had MPO EIA values in the positive range (ie,
>control mean + 2 SD). Both positive lupus patients had
over 50% crescent formation and segmental glomerular
necrosis. One patient had severe hemoptysis with mas-
sive pulmonary consolidation radiographically.
Sera from 72 randomly chosen patients who under-
went renal biopsy for diseases other than those already
discussed were also analyzed by IIFM and EIA for ANCA.
Of these, only four (6%) were positive by IIFM. The 72
sera had a mean EIA value of 23.1, and only eight
Figure 3. EIA using purified MPO as anti-
gen to assess the reactivity ofP-ANCA sera
from 45patients, C-ANCA serafrom 29pa-
tients, and ANCA-negative sera for 27pa-
tients. The dashed line represents the
ANCA-negative sera mean plus 2 SD. Note
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Table 2. Pathologic Findings in Patients withANCA-Associated Glomerulonepbritis
All C-ANCA P-ANCA A B C D
Any crescents 75/81 32/34 43/47 17/20 12/12 20/21 10/12
Greater than 50% crescents (%) 30/81 11/34 19/47 9/20 4/12 7/21 1/12
Glomerular necrosis 76/81 32/34 44/47 17/20 11/12 21/12 12/12
Arteritis in the renal biopsy 10/81 4/34 6/47 0/20 3/12 0/21 3/12
Greater than 1 + immunoglobulin by
immunofluorescence 10/71 3/31 7/40 4/18 0/11 1/18 1/11
Dense deposits by electron
microscopy 11/69 5/31 6/38 3/16 0/11 2/17 1/11
A, no extrarenal disease; B, extrarenal but no lung disease; C, extrarenal with lung but no sinus disease; D, extrarenal with lung and sinus disease.
(11 %) were considered positive (ie, had values greater
than 42.2).
None of the 83 blood bank specimens gave a positive
ANCA reaction by IIFM. These samples had a mean EIA
of 23.2 with a standard deviation of 9.5. In separate EIA
procedures, 33 determinations on the EIA standard nega-
tive control specimen yielded a mean value of 19.1 with a
standard deviation of 8.4.
Frequency ofANCA-Associated
Glomerulonephritis
From our data we cannot directly determine the frequency
of ANCA-associated glomerulonephritis relative to other
forms of glomerulonephritis; however, we can infer this
from the frequency of ANCA in patients with the three
major categories of glomerulonephritis (ie, immune com-
plex-mediated, anti-GBM antibody-mediated, and pauci-
immune) and from the relative frequency of the three ma-
jor categories of glomerulonephritis among all patients
with glomerulonephritis.
Of 1500 consecutive nontransplant renal biopsies,
15% had some degree of crescent formation. Of glomeru-
lonephritis with any degree of crescent formation, 51%
were pauci-immune, 44% immune complex-mediated,
and only 5% anti-GBM antibody mediated. The frequency
of pauci-immune glomerulonephritis was even greater in
patients with greater than 50% crescent formation (50%),
glomerular necrosis (60%), or arteritis in the renal biopsy
specimen (81%). Because approximately 80% of patients
with pauci-immune glomerulonephritis with crescents
have ANCA, it can be inferred that ANCA-associated glo-




The pathologic findings in 81 patients with glomerulone-
phritis and positive IIFM serology for ANCA were evalu-
ated (Table 2). By definition, all 81 patients had ANCA by
IIFM; 34 had C-ANCA, and 47 had P-ANCA. Their mean
screening EIA level was 83.7 ± 36.8 with 89.0% having a
value greater than the control mean plus 2 SD.
The 81 patients ranged in age from 2 to 86 years, with
a mean of 57 years (±17.5) and a median of 60 years.
The male-to-female ratio was 43 to 38. At the time of bi-
opsy, the patients had a mean creatinine of 5.8 ± 4.6 mg/
dl (range, 0.7 to 20.1). Of 79 patients tested for antinu-
clear antibodies using HEp-2 cells, 14 (18%) were positive
at a serum dilution of 1:20 and produced a variety of pat-
terns. Of 79 patients tested for anti-DNA antibodies using
Crithedia luciliae, none were positive at a serum dilution
of 1:20.
Based on the immunohistologic criteria, none of the 81
had anti-GBM antibody-mediated glomerulonephritis and
only four met the criteria set for immune complex-medi-
ated glomerulonephritis. All of the latter had no more than
2+ immunostaining for immunoglobulin and had only rela-
tively small scattered electron dense deposits ultrastruc-
turally.
The most frequent histologic appearance was focal
segmental glomerular fibrinoid necrosis with crescent for-
mation and only mild hypercellularity (Figures 4 and 5).
Neutrophils in general were not conspicuous but were fre-
quently present at sites of necrosis. In a few cases, a
granulomatous response was noted adjacent to glomeruli
that had necrosis and disruption of Bowman's capsule
(Figure 5).
By immunofluorescence microscopy, only 14% of 71
patients with ANCA-associated glomerulonephritis had
greater than 1+ immunostaining for any immunoglobulin
and these cases had only 2+ staining. When present, im-
munoglobulin staining was usually predominantly within
the mesangium. Irregular immunostaining for fibrin was
present in necrotic segments and within crescents. Irreg-
ular immunostaining for C3, Cl q, and IgM was present at
sites of glomerular sclerosis.
By electron microscopy only 16% of 69 patients with
ANCA-associated glomerulonephritis had any glomerular
electron dense deposits; these were relatively small, scat-
tered deposits, most often confined to the mesangium.
No endothelial tubuloreticular inclusions were identified.
In necrotic segments, disruption of glomerular basement
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Figure 4. ANCA-associated glomerulonephritis with character-
istic segmental fibrinoid necrosis (H&E, original magnifica-
tion X375).
membranes was noted. This was often associated with
capillary thrombosis and extension of fibrin tactoids into
adjacent crescents. Occasional glomerular capillaries, es-
r~~~~~~~~~I-_%w
Figure 5. ANCA-associated glomerulonephritis with crescent
formation, focal disruption ofBowman 's capsule, and a peri-
glomerular granuloma with multinucleated giant cells (ar-
row) (Silver methenamine, original magnification X460).
Table 3. Correlation ofExtrarenal Disease
Distribution withANCA*
All A B C D
C-ANCA-GN 34 4 7 8 8
(42%) (20%) (58%) (38%) (67%)
P-ANCA-GN 47 16 5 13 4
(58%) (80%) (42%) (62%) (33%)
Total 81 20 12 21 12
(100%) (100%) (100%) (100%) (100%)
Determined in 81 patients with ANCA-associated GN, 65 of whom
were categorzed on the basis of clinical data into categories A (no extrare-
nal disease), B (extrarenal but no lung disease), C (extrarenal and lung but
no sinus disease), and D (extrarenal with lung and sinus disease).
pecially in necrotic segments, contained marginated neu-
trophils and mononuclear phagocytes.
Table 2 indicates that there were no substantial differ-
ences in the pathologic glomerular changes between pa-
tients with C-ANCA versus P-ANCA, or among patients
with different degrees of extrarenal vascular inflammation.
Periglomerular granulomas were observed more often in
patients with C-ANCA, although most patients with C-
ANCA did not have periglomerular granulomas. There
was a small tendency for P-ANCA patients to have slightly
more glomerular immune deposition than C-ANCA pa-
tients; patients with renal-limited disease, likewise, had
slightly more glomerular immune deposition than patients
with systemic disease. In all groups, however, by far the
preponderant characteristic was the paucity of immune
deposits.
Distribution of Systemic Disease in Patients
with ANCA-Associated Glomerulonephritis
Table 3 summarizes the distribution of extrarenal disease
in patients with ANCA-associated glomerulonephritis, and
correlates this with the ANCA type. Thorough clinical, lab-
oratory, and pathologic data were available on 65 patients
that permitted them to be categorized into groups A, B,
C, or D based on the distribution of disease. Because of
our selection method, all patients had glomerulonephritis.
Thus, the frequency of the various distributions of disease
in ANCA-positive patients only pertains to patients with
ANCA-associated glomerulonephritis.
The data in Table 3 indicate that patients with ANCA-
associated glomerulonephritis with no evidence for sys-
temic disease, a category that would include most pa-
tients with so-called idiopathic or primary crescentic glo-
merulonephritis, most often had P-ANCA rather than
C-ANCA. Nevertheless, some patients with C-ANCA had
glomerulonephritis with absolutely no evidence of extrare-
nal disease. Patients with lung and sinus involvement had
the highest frequency of C-ANCA relative to P-ANCA, but
even in this group some patients had P-ANCA. As will be
discussed later, pathologically documented ANCA-asso-
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Figure 6. ANCA-associated renal medullary leukocytoclastic
capillaritis (H&E, original magnification X200).
ciated granulomatous respiratory tract inflammation may
be strongly correlated with C-ANCA, although patients
with alveolar capillaritis can have C-ANCA or P-ANCA.
Necrotizing arteritis in the renal biopsy was not confined
to any one of the clinical or serologic categories.
Pathologic Characteristics ofANCA-
Associated Systemic Vasculitis
In patients with ANCA-associated disease, varying de-
grees of necrotizing inflammation of capillaries, venules,
arterioles, and arteries were observed in the kidneys,
lungs, skin, nasal mucosa, and other organs. A ubiquitous
feature was the presence of vascular fibrinoid necrosis,
usually accompanied by leukocytic infiltration with varying
degrees of leukocytoclasia. At some sites either neutro-
phils or mononuclear leukocytes were predominant,
whereas at others there were admixtures of both. One
patient, who did not have asthma, had conspicuous eo-
sinophils within the inflammatory infiltrates. Examination
by immunofluorescence microscopy of skin and lung tis-
sue with vasculitis demonstrated no immune complex de-
posits. Examination by electron microscopy of lung tissue
with alveolar capillaritis revealed no vascular electron
dense deposits.
Three kidney biopsy specimens were found to have a
medullary peritubular necrotizing leukocytoclastic capillar-
itis (Figure 6). The frequency of this lesion's occurrence
cannot be determined because of its focal nature and the
lack of medullary tissue in many of the biopsies.
Of seven skin biopsies examined, five had a severe
necrotizing leukocytoclastic angiitis, one had a pannicu-
litis with necrotizing arteritis, and one had perivascular
scarring and chronic inflammation.
Table 4 summarizes the respiratory tract lesions identi-
fied in patients with ANCA-associated glomerulonephritis.
The most frequent lung lesion was a striking alveolar capil-
laritis (Figure 7) characterized by marked margination of
neutrophils along alveolar capillaries and focal necrosis of
alveoli with spillage of neutrophils into alveolar spaces.
This lesion was associated with extensive alveolar hemor-
rhage, and the patients characteristically had hemoptysis,
dyspnea, and pulmonary infiltrates radiographically.
Pulmonary granulomas were documented pathologi-
cally in four patients. In three of these, the lesions were
granulomas characteristic of Wegener's granulomatosis
with central irregular necrosis, degenerating neutrophils,
and marginal mononuclear leukocytes, including multinu-
cleated giant cells. In one patient, however, the granulo-
mas were more discrete and were found to contain myco-
bacteria both histochemically and by culture. The first
three patients all had C-ANCA and the latter patient had P-
ANCA. Therefore, all three patients with Wegener's-type
granulomas had C-ANCA. However, not all patients with
C-ANCA had granulomas at the sites of vasculitis and in-
flammation. Seven patients with C-ANCA had alveolar
capillaritis without granulomas, including one C-ANCA pa-
tient who at autopsy was found to have a pauci-immune
focal necrotizing and crescent-forming glomerulonephri-
tis and severe hemorrhagic necrotizing alveolar capillaritis
(with no immune deposits by immunofluorescence mi-
croscopy) but no granulomatous inflammation or arteritis.
Alveolar interstitial fibrosis was present alone or was
associated with granulomas or capillaritis in most pa-
tients. Some patients with alveolar capillaritis showed an
apparent transition in some areas between the acute in-
jury and a pattern of sclerosing diffuse alveolar damage,
usually accompanied by hemosiderin-laden macro-
phages. In one patient, an initial lung biopsy showed
acute alveolar capillaritis with hemorrhage, whereas a
subsequent biopsy showed only diffuse interstitial fi-
brosis.
Eight nasal biopsies were evaluated. Patients with ei-
ther P-ANCA or C-ANCA frequently had a lesion manifest-
ing as a necrotizing acute inflammation, often with con-
spicuous margination of neutrophils along the microvas-
culature. Two nasal biopsies from patients with C-ANCA
had granulomas and one had a necrotizing arteritis.
Discussion
Our data show that both C-ANCA and P-ANCA are asso-
ciated with necrotizing vasculitis affecting vessels ranging
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Table 4. Pathologic Findings in 15 Lung Specimens*
Specimen 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
ANCA type C C C P C C P C C C C C P C C
Lung tissue
Specimen type 0 T 0 0 0 A 0 0 0 0 0 T 0 0 R
Granulomas + + + +t -
Capillaritis - - - - + + + + + + + + +
Hemorrhage - - - - + + + + + + + +
Fibrosis + + + + - - - - + + + + + + +
Nasal tissue
Granulomas + N - N N N - - N N N N N N -
Necrotizing acute inflammation + N - N N N + + N N N N N N +
* Five of the specimens had accompanying nasal mucosa. The specimens were from patients with ANCA-associated glomerulonephritis and lung
disease.
t Most likely tuberculous granulomas.
0, open biopsy; T, transbronchial biopsy; A, autopsy specimen; R, resected lobe; N, not available.
in size from capillaries to muscular arteries in many differ-
ent tissues. Based on clinicopathologic criteria, some of
our 81 patients with ANCA-associated glomerulonephritis
would be diagnosed as having idiopathic (primary) cres-
centic glomerulonephritis, polyarteritis nodosa, or Wegen-
er's granulomatosis. However, most fall within a contin-
uum of clinicopathologic features extending from renal-
limited disease to extensive extrarenal disease. By
definition, all of the patients in our study had nephritis,
but other researchers have reported patients with ANCA-
associated disease and no apparent renal involvement.12
We propose that all patients who have ANCA may share
Figure 7. ANCA-associated pulmonary alveolar capillaritis.
Note the striking influx ofneutrophils and the massive hemor-
rhage into the alveolar spaces (H&E, original magnification
X 750).
a common pathogenetic mechanism that causes different
distributions of vascular injury in different patients and in
the same patients at different times.
There has been some debate about the diagnostic
specificity of C-ANCA for Wegener's granulomatosis.12
There is no doubt that C-ANCA is a sensitive marker for
active Wegener's granulomatosus when this disease is
defined by criteria that include the pathologic identifica-
tion of granulomas in the respiratory tract. However, our
data and that of others indicate that not all patients with
C-ANCA can be identified as having Wegener's granulo-
matosis by any previously recognized criteria. The propor-
tion of C-ANCA patients without feature's of Wegener's
granulomatosis who will eventually develop such features
is unknown.
We have unpublished data suggesting that ANCA are
not only associated with vasculitis but in fact are involved
in the pathogenesis of necrotizing vasculitis. In vitro, IgG
isolated from P-ANCA- or C-ANCA-positive sera cause a
respiratory burst and degranulation of viable normal hu-
man neutrophils. This event is facilitated by first priming
the neutrophils. Priming is known to cause the release of
small amounts of primary granule constituents at the cell
surface that can then interact with ANCA to cause total
activation with release of toxic oxygen radicals and lytic
enzymes. We postulate that, in patients with ANCA, a trig-
gering event, such as a viral infection, primes neutrophils
in the circulation allowing for ANCA-induced neutrophil
activation with resultant vascular injury. The site of vascu-
lar injury may be influenced by local concentrations of cy-
tokines or by the physiology of leukocyte trafficking
through a given vessel. For example, the propensity for
patients with ANCA to develop upper and lower respira-
tory tract vasculitis after viral respiratory tract infections
could be a result of the availability of cytokine-primed neu-
trophils and mononuclear phagocytes at the site of viral
infection.
In conclusion, ANCA are associated with pauci-im-
mune necrotizing glomerulonephritis and systemic vascu-
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litis. ANCA should be a useful diagnostic serologic marker
for these diseases, and may be helpful in monitoring the
course of the disease and response to treatment. ANCA
of different specificities are associated with different distri-
butions of vasculitis. It is possible that ANCA are directly
involved in a novel pathogenetic mechanism that is re-
sponsible for causing common forms of crescentic glo-
merulonephritis and necrotizing systemic vasculitis.
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